Latin America, Middle East & Africa Biosurgery Market (2019-2025)

Latin America, Middle East & Africa Biosurgery Market (2019-2025)

  • December 2019 •
  • 100 pages •
  • Report ID: 5838717 •
  • Format: PDF
The Latin America, Middle East and Africa Biosurgery Market would witness market growth of 7.4% CAGR during the forecast period (2019-2025).

Biological products can be used in several applications in orthopedic surgeries. Postoperative blood loss is a crucial issue that leads to a high rate of mortality. In order to prevent excessive blood loss at the time of hip and knee arthroplasty, hemostatic agents like intravenous tranexamic acid are used. The biosurgery market has been projected to benefit from enormous latent opportunities in an increased number of surgeries across the world. A wide range of surgeries is meant to treat sports-related and severe trauma injuries. The market is also expected to bring in significant gains from the rapidly aging population in the emerging countries.

Biosurgery applications are used to treat a wide range of ailments. Neurosurgery and spine surgery treats diseases concerned with the nervous system. It includes the spinal cord, brain, peripheral nervous system, as well as extra-cranial cerebrovascular system. Cardiovascular and thoracic surgical treatments can be conducted for diseases that are associated with coronary arteries, heart, major blood vessels, lungs, chest, and esophagus.

The Latin America Bio Surgery market’s main driver is the increased approval by regulatory authorities of biosurgery products. Furthermore, the rising number of surgeries, increasing geriatric populations, changes in lifestyle and increasing need for effective management of blood loss, supports the region’s market growth. However, there are little-to-no reimbursements for products of biosurgery and the associated costs are usually too high to be used by the general public. This in general, together with the rising costs of surgical procedures, acts as market restrictions.

Based on Application, the market is segmented into General Surgeries, Orthopedic Surgeries, Neurological Surgeries, Cardiovascular Surgeries and Other Applications. Based on Product, the market is segmented into Surgical sealants, Soft Tissue Attachments, Adhesion Barriers, Hemostatic Agents, Bone Graft Substitutes and Other Products. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Baxter International, Inc., Johnson and Johnson, Medtronic PLC, Pfizer, Inc., Stryker Corporation, B. Braun Melsungen AG, Sanofi S.A., Becton, Dickinson and Company, Integra LifeSciences Holdings Corporation and CSL Limited.

Scope of the Study

Market Segmentation:

By Application

• General Surgeries

• Orthopedic Surgeries

• Neurological Surgeries

• Cardiovascular Surgeries

• Other Applications

By Product

• Surgical Sealants

• Soft Tissue Attachments

• Adhesion Barriers

• Hemostatic Agents

• Bone Graft Substitutes

• Other Products

By Country

• Brazil

• Argentina


• Saudi Arabia

• South Africa

• Nigeria

• Rest of LAMEA

Companies Profiled

• Baxter International, Inc.

• Johnson and Johnson

• Medtronic PLC

• Pfizer, Inc.

• Stryker Corporation

• B. Braun Melsungen AG

• Sanofi S.A.

• Becton, Dickinson and Company

• Integra LifeSciences Holdings Corporation

• CSL Limited

Unique Offerings

• Exhaustive coverage

• Highest number of market tables and figures

• Subscription based model available

• Guaranteed best price

• Assured post sales research support with 10% customization free